Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance

Lancet

Volumn 359, Issue 9311, 2002, Pages 1026-1031

  Bastard, Jean Philippe ^a,b   Caron, Martine ^a   Vidal, Hubert ^a   Jan, Véronique ^b   Auclair, Martine ^a   Vigouroux, Corinne ^a,c   Luboinski, Jacqueline ^c   Laville, Martine ^a   Maachi, Mustapha ^b   Girard, Pierre Marie ^c   Rozenbaum, Willy ^c   Levan, Philippe ^c   Capeau, Jacqueline ^a,b,c,d  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

^c HÔPITAL ROTHSCHILD   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CELL MARKER; CYTOKINE; GLUCOSE; INSULIN; ISOPROTEIN; LEPTIN; LIPID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEINASE INHIBITOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DRUG TARGETING; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; INSULIN RESISTANCE; LIPID ANALYSIS; LIPOATROPHY; MALE; METABOLIC DISORDER; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 0037161026     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08094-7     Document Type: Article

References (35)

1. Diagnosis, prediction, and natural course of HIV-1 protease inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
2. Metabolic complications associated with antiretroviral therapy
3. Antiretroviral therapy and the lipodystrophy syndrome, part 2: Concepts in aetiopathogenesis
4. Metabolic effects of indinavir in healthy HIV-seronegative men
5. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects
6. Adverse effects of antiretroviral therapy
7. Lipodystrophies
8. Life without white fat: A transgenic mouse
9. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
10. Transcriptional regulation of adipogenesis
11. Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: Implications for adipocyte differentiation and metabolism
12. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance
13. Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors
14. HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus
15. HIV protease inhibitor-induced hyperlipidemia and lipodystrophy is mediated through regulation of sterol responsive element binding protein (SREBP) responsive genes
16. Differential in vitro effect of indinavir, nelfinavir and amprenavir on cell differentiation, insulin sensitivity and apoptosis in an adapted adipose cell model: Preventive impact of roziglitazone
17. Mitochondrial toxicity hypothesis for lipoatrophy: A refutation
18. Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy
19. Autologous fat transplantation
20. Quantification of lipid-related mRNAs by reverse transcription-competitive polymerase chain reaction in human white adipose tissue biopsies
21. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells
22. The use of the reverse transcription-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples
23. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes
24. Tumor necrosis factor-alpha induces apoptosis of human adipose cells
25. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes
26. Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway
27. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses
28. Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene
29. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection: Correlations to clinical, immunologic, and virologic parameters
30. Adipose tissue as an endocrine and paracrine organ
31. TNF-alpha inhibits 3T3-L1 adipocyte differentiation without downregulating the expression of C/EBPbeta and delta
32. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
33. A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia
34. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes
35. Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus